Physician profile
Janson Rigby
NPI 1538622626
$4,184.16
in general payments reported to CMS, 2019-2025
14 companies · $101 in 2025
The $101 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $122 · 2021: $631 · 2022: $1,421 · 2023: $1,246 · 2024: $663 · 2025: $101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,010.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,009.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,127.49 | 2021-2024 | Hydrus Microstent, Clareon, Centurion |
| Sight Sciences, INC. | $603.95 | 2021-2023 | Omni Surgical System |
| Horizon Therapeutics Plc | $392.88 | 2021-2023 | Tepezza |
| Regeneron Healthcare Solutions, INC. | $368.19 | 2021-2024 | Eylea Hd |
| Abbvie INC. | $338.88 | 2022-2024 | Durysta |
| Astellas Pharma US INC | $329.97 | 2023-2025 | Izervay |
| Allergan, INC. | $190.39 | 2021-2022 | |
| Ivantis, INC | $163.33 | 2021 | |
| Microsurgical Technology, INC. | $152.48 | 2022 | |
| Alexion Pharmaceuticals, INC. | $121.85 | 2019 | |
| Bausch & Lomb Americas INC. | $118.77 | 2023-2025 | Miebo, Xiidra |
| Glaukos Corporation | $115.19 | 2022 | |
| Biotissue Holdings INC. | $112.29 | 2024 | |
| Apellis Pharmaceuticals, INC. | $48.50 | 2025 | Syfovre |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janson Rigby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.